A series of reports released today by the European Centre for Disease Prevention and Control (ECDC) show sexually transmitted ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or ...

Antibiotics are a powerful tool in fighting bacterial infections like strep throat, whooping cough or a urinary tract infection. But they can leave the patient with nausea, diarrhea or an upset ...

Malfertheiner et al. (2007) Europe (Maastricht III) PPI (standard dose b.i.d.) Clarithromycin (500 mg b.i.d.) Amoxicillin (1000 mg b.i.d.) or metronidazole (400 mg b.i.d.) 7–14 In populations ...

The tests aim to reduce the use of antibiotics and therefore antimicrobial resistance, which is rising globally. A pilot trial will begin later this year, applying the tests in rural settings with ...

Antibiotics are a powerful tool in fighting bacterial infections like strep throat, whooping cough or a urinary tract infection. But they can leave the patient with nausea, diarrhea or an upset ...